• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INVIVE; CARDIAC RESYNCHRONIZATION THERAPY PACEMAKER (CRT-P)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INVIVE; CARDIAC RESYNCHRONIZATION THERAPY PACEMAKER (CRT-P) Back to Search Results
Model Number V173
Device Problems Over-Sensing (1438); Pacing Problem (1439); Incorrect, Inadequate or Imprecise Result or Readings (1535); Inappropriate or Unexpected Reset (2959)
Patient Problems Presyncope (4410); Asystole (4442)
Event Date 10/02/2023
Event Type  Injury  
Event Description
It was reported that this cardiac resynchronization therapy pacemaker (crt-p) had reached elective replacement indicator (eri) and entered safety mode.It was noted that the patient was feeling fine until device interrogation, and experienced near syncope and approximately three seconds of asystole.It was suspected that the device had entered safety mode upon interrogation, and the patient was admitted to the hospital until the scheduled device replacement.The crt-p was explanted and replaced the next day.No additional adverse patient effects were reported.This crt-p was returned for analysis.
 
Manufacturer Narrative
The product has been received for analysis.This report will be updated upon completion of analysis.
 
Event Description
It was reported that this cardiac resynchronization therapy pacemaker (crt-p) had reached elective replacement indicator (eri) and entered safety mode.It was noted that the patient was feeling fine until device interrogation and experienced near syncope and approximately three seconds of asystole.It was suspected that the device had entered safety mode upon interrogation, and the patient was admitted to the hospital until the scheduled device replacement.The crt-p was explanted and replaced the next day.No additional adverse patient effects were reported.This crt-p was returned for analysis.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, this device was thoroughly inspected and analyzed.Interrogation of the device confirmed it was operating in safety mode/determined it had undergone resets and that bradycardia therapy remained available.The system resets occurred during a telemetry session or while communicating with the latitude remote monitoring system caused the device to enter safety mode.Engineers determined that this device was demonstrating behavior consistent with a high internal cell impedance within the battery.The high internal impedance resulted in the system resets due to temporary high-power consumption and subsequent reversion to safety mode operation.Boston scientific has issued a field safety notice regarding ingenio extended life (el) and cardiac resynchronization therapy pacemaker (crt-p) devices that may exhibit this behavior.This particular device is included in the high impedance in ingenio extended life (el) pacemaker and crt-p advisory population.The product has been received for analysis.This report will be updated upon completion of analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INVIVE
Type of Device
CARDIAC RESYNCHRONIZATION THERAPY PACEMAKER (CRT-P)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17950093
MDR Text Key325854948
Report Number2124215-2023-57544
Device Sequence Number1
Product Code NKE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030005/S079
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date 04/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/13/2015
Device Model NumberV173
Device Catalogue NumberV173
Device Lot Number103437
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/11/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/02/2023
Initial Date FDA Received10/17/2023
Supplement Dates Manufacturer Received04/09/2024
Supplement Dates FDA Received04/23/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/16/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age87 YR
Patient SexMale
-
-